Concentrix Q3 Earnings Expected to Rise to $2.81 per Share

Concentrix is set to report Q3 results on Sept. 29, with analysts projecting a slight EPS increase and flat revenue of $2.48 billion.
Key points
- Concentrix is expected to report Q3 earnings of $2.81 per share, up slightly from $2.78 in the year-ago period.
- Analyst consensus projects quarterly revenue of $2.48 billion, matching the figure from the same quarter last year.
- Three top analysts cut price targets between $30 and $32 in June 2026, reflecting cautious sentiment ahead of the release.
Concentrix Corporation (NASDAQ:CNXC) is scheduled to release its third-quarter financial results on Tuesday, Sept. 29, following the market close. The Newark, California-based company faces expectations for a modest increase in profitability, with the consensus estimate pointing to earnings of $2.81 per share. This figure represents a slight rise from the $2.78 per share reported in the same period last year, indicating stable but limited growth in the near term.
Revenue expectations remain flat year-over-year, with analysts projecting $2.48 billion for the current quarter, matching the figure reported in the prior year’s third quarter. According to data from Benzinga Pro, this stagnation in top-line growth suggests that Concentrix is maintaining its market position without significant expansion in billable hours or new contract wins during this specific period. The company’s recent strategic move to acquire CastleHill Managed Risk Solutions on Sept. 8 may not yet be reflected in these immediate quarterly figures.
Recent Analyst Target Revisions
Ahead of the earnings release, several analysts with high historical accuracy have revised their outlooks downward, reflecting a cautious stance on the stock’s valuation. On June 30, 2026, B of A Securities analyst Ruplu Bhattacharya maintained a Neutral rating but cut the price target from $32 to $26. This adjustment aligns with a 70% accuracy rate for the analyst, suggesting a realistic reassessment of the company’s near-term potential.
Barrington Research analyst Vincent Colicchio also adjusted his forecast on the same date, maintaining an Outperform rating while reducing the price target from $38 to $30. Colicchio holds a 63% accuracy rate. Similarly, Baird analyst David Koning kept his Outperform rating but slashed the price target significantly from $40 to $30. Koning’s 69% accuracy rate underscores that these revisions are based on rigorous performance metrics rather than speculative optimism.
Market Reaction and Stock Performance
Investor sentiment appears tempered as Concentrix shares declined by 1.7% to close at $27.87 on Friday. This drop occurs against the backdrop of the recent price target cuts, which have brought the consensus target closer to the current trading price. The market’s reaction indicates that investors are scrutinizing the company’s ability to convert its stable revenue base into higher margins, particularly as the acquisition of CastleHill adds complexity to its operational structure.
The flat revenue projection and modest EPS increase suggest that Concentrix is in a consolidation phase. While the acquisition of CastleHill Managed Risk Solutions may offer long-term synergies, the immediate financial metrics show little deviation from previous quarters. The upcoming earnings call will likely focus on how management intends to leverage this new asset to drive future growth, rather than reporting immediate financial windfalls.






